|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Access Pharmaceuticals Inc., of Dallas, entered a research collaboration with an unnamed pharmaceutical company to combine its vitamin B12 oral drug delivery technology with the collaborator's formulations to provide oral drug delivery options for those formulations. Access's vitamin B12 oral drug delivery technology uses a body's receptor-mediated transport system for vitamin B12 to assist in the absorption of drugs in the gut. Financial terms were not disclosed.
o Agencourt Bioscience Corp., of Beverly, Mass., launched an expanded single nucleotide polymorphism (SNP) discovery service for pre-validated sequencing assays of kinases. Agencourt signed a ...